World's Best Scientists 2026 revealed!
Shaun G. Goodman

Shaun G. Goodman

D-Index & Metrics

Medicine

D-Index
112
Citations
57535
World Ranking
5075
National Ranking
198

Overview

Shaun G. Goodman is affiliated with the University of Toronto in Canada and has an extensive publication record primarily in the field of Medicine. Their research is focused on Cardiology and Cardiovascular Medicine, Surgery, Economics and Econometrics, Endocrinology, Diabetes and Metabolism, and Radiology, Nuclear Medicine and Imaging.

The main topics of their work include:

  • Lipoproteins and Cardiovascular Health
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Acute Myocardial Infarction Research
  • Atrial Fibrillation Management and Outcomes
  • Health Systems, Economic Evaluations, Quality of Life
  • Cardiac Imaging and Diagnostics
  • Coronary Interventions and Diagnostics

Goodman has published frequently in several prominent cardiology journals, including:

  • Journal of the American College of Cardiology
  • Circulation
  • European Heart Journal
  • Canadian Journal of Cardiology
  • CJC Open

Their notable recent papers include:

  • "Initial Invasive or Conservative Strategy for Stable Coronary Disease," 2020, New England Journal of Medicine
  • "Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome," 2020, Journal of the American College of Cardiology
  • "Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention," 2020, JAMA
  • "Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention," 2021, Circulation
  • "Empagliflozin after Acute Myocardial Infarction," 2024, New England Journal of Medicine

Throughout their career, Goodman has collaborated regularly with a core group of coauthors including Philippe Gabríel Steg, Deepak L. Bhatt, Harvey D. White, Michael Szarek, and J. Wouter Jukema.

Their research contributions center around cardiology-focused clinical studies and trials, particularly concerning coronary disease strategies, lipid management, antiplatelet and antithrombotic therapies, and outcomes after acute myocardial infarction. Goodman's work also involves integrating aspects of health systems and economics within cardiovascular care.

Best Publications

  • Predictors of hospital mortality in the global registry of acute coronary events.

    Christopher B. Granger;Robert J. Goldberg;Omar Dabbous;Karen S. Pieper

  • A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group.

    M. Cohen;C. Demers;E. P. Gurfinkel;A. G. G. Turpie

  • A validated prediction model for all forms of acute coronary syndrome:estimating the risk of 6-month postdischarge death in an international registry

    Kim A Eagle;Michael J Lim;Omar H Dabbous;Karen S Pieper

  • Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)

    Keith A A Fox;Omar H Dabbous;Robert J Goldberg;Karen S Pieper

  • Initial invasive or conservative strategy for stable coronary disease.

    David J. Maron;Judith S. Hochman;Harmony R. Reynolds;Sripal Bangalore

  • Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

    Adrian F Hernandez;Jennifer B Green;Salim Janmohamed;Ralph B D'Agostino

  • Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome

    John H. Jh Alexander;RD D Renato D. Rd Renato D Lopes;Stefan James;Rakhi Kilaru

  • Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial.

    James J Ferguson;Robert M Califf;Elliott M Antman;Marc Cohen

  • Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006

    Keith A A Fox;Philippe Gabriel Steg;Kim A Eagle;Shaun G Goodman

  • Prasugrel versus clopidogrel for acute coronary syndromes without revascularization

    Matthew T. Roe;Paul W. Armstrong;Keith A.A. Fox;Harvey D. White

  • Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation

    R.D. Lopes;G. Heizer;R. Aronson;A.N. Vora

  • Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38

    Stephen D. Wiviott;Eugene Braunwald;Dominick J. Angiolillo;Simha Meisel

  • Routine Early Angioplasty after Fibrinolysis for Acute Myocardial Infarction

    Warren J. Cantor;David Fitchett;Bjug Borgundvaag;John Ducas

  • Intravenous Platelet Blockade with Cangrelor during PCI

    Deepak L. Bhatt;A. Michael Lincoff;C. Michael Gibson;Gregg W. Stone

  • Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE).

    Kim A Eagle;Shaun G Goodman;Álvaro Avezum;Andrzej Budaj

  • Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease

    A. Michael Lincoff;Stephen J. Nicholls;Jeffrey S. Riesmeyer;Philip J. Barter

  • Platelet Inhibition with Cangrelor in Patients Undergoing PCI

    Robert A. Harrington;Gregg W. Stone;Steven McNulty;Harvey D. White

  • Prehospital Ticagrelor in ST-Segment Elevation Myocardial Infarction

    Gilles Montalescot;Arnoud W. van 't Hof;Frédéric Lapostolle;Johanne Silvain

  • Acute Coronary Syndromes Without Chest Pain, An Underdiagnosed and Undertreated High-Risk Group: Insights From The Global Registry of Acute Coronary Events

    David Brieger;Kim A. Eagle;Shaun G. Goodman;P. Gabriel Steg

  • Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial.

    Investigators;John H Alexander;Richard C Becker

Frequent Co-Authors

Harvey D. White
Harvey D. White Auckland City Hospital
Christopher B. Granger
Christopher B. Granger Duke University
Keith A.A. Fox
Keith A.A. Fox University of Edinburgh
Robert A. Harrington
Robert A. Harrington Cornell University
Deepak L. Bhatt
Deepak L. Bhatt Mount Sinai Hospital
Paul W. Armstrong
Paul W. Armstrong University of Alberta
Matthew T. Roe
Matthew T. Roe Duke University
Kenneth W. Mahaffey
Kenneth W. Mahaffey Stanford University
Vera Bittner
Vera Bittner University of Alabama at Birmingham
Rafael Diaz
Rafael Diaz University of Alberta

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online healthcare degrees is a convenient way to launch or advance your medical career in the USA. For registered nurses, online rn-bsn programs without clinicals make it easier to earn a bachelor's degree while managing work and family commitments, thanks to a flexible format and limited in-person requirements.

Nurses seeking leadership or specialized roles can choose from a variety of doctoral programs. Some learners prioritize speed and flexibility, making the fastest online dnp programs a popular option. Others may seek less demanding academic routes, gravitating toward dnp programs without dissertation to streamline their studies and focus on clinical practice rather than research.

If you're just starting out, there are fastest lpn program options online for those eager to enter the workforce quickly as a Licensed Practical Nurse. These accelerated routes can help you gain valuable experience and skills in a short amount of time, setting the stage for future educational and career growth.

Best Scientists Citing Shaun G. Goodman

Trending Scientists

Recently Published Articles